Browsing by Author "Hasegawa, K."

Now showing 1 - 5 of 5

ENGOT-EN9/LEAP-001: A PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB PLUS LENVATINIB COMPARED WITH CHEMOTHERAPY IN ADVANCED OR RECURRENT ENDOMETRIAL CANCER
(2020) Randall, L.; Marth, C.; Vulsteke, C.; Rubio, M. Jesus; Makker, V.; Braicu, I.; McNeish, I.; Madry, R.; Ayhan, A.; Hasegawa, K.; Wu, X.; Dutta, L.; Xu, C.; Keefe, S.; Lee, J.; Pignata, S.
ENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial cancer
(2020) Marth, C.; Vulsteke, C.; Rubio, M. J. R.; Makker, V.; Braicu, E. I.; McNeish, I. A.; Madry, R.; Ayhan, A.; Hasegawa, K.; Wu, X.; Dutta, L.; Xu, C.; Keefe, S.; Lee, J.; Pignata, S.; AAJ-5802-2021
ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer
(2019) Marth, C.; Vulsteke, C.; Rubio, M. J.; Makker, V.; Braicu, E. I.; McNeish, I. A.; Radoslaw, M.; Ayhan, A.; Hasegawa, K.; Wu, X.; Dutta, L.; Xu, C.; Keefe, S. M.; Lee, J.; Pıgnata, S.
ENGOT-Ov65/KEYNOTE-B96: Phase III, Randomized, Double-Blind Study Of Pembrolizumab Vs Placebo Plus Paclitaxel With Optional Bevacizumab For Platinum-Resistant Recurrent Ovarian Cancer
(2022) Colombo, N.; Coleman, R. L.; Wu, X.; Kose, F.; Wenham, R.; Sebastianelli, A.; Hasegawa, K.; Zsiros, E.; Rouge, T. De La Motte; Bidzinski, M.; McNeish, I.; Sehouli, J.; Korach, J.; Debruyne, P. R.; Kim, J-W.; De Melo, A. C.; Peng, X.; Bogusz, A. M.; Yamada, K.; Monk, B. J.
Pembrolizumab Plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer: A Randomized, Doubleblind, Phase III ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study
(2023) Lorusso, D.; Xiang, Y.; Hasegawa, K.; Scambia, G.; Galves, M. H. Leiva; Elias, P. Ramos; Acevedo, A.; Vizkeleti, J.; Gomes, A. J. P. D. S.; Mejia, F. Contreras; Reiss, A.; Ayhan, A.; Lee, J. Y.; Saevets, V.; Zagouri, F.; Li, K.; Yamada, K. Ussui; Toker, S.; Pignata, S.; Duska, L. R.